Epigral share news and announcements
NSE: EPIGRALBSE: 543332Chemicals & PetrochemicalsSmall Cap
Formerly Meghmani Finechem
Last close ₹895.00down ₹26.20 (2.84%)BSE ₹897.70
Share price at the NSE close on 23 Oct 2026. Previous close ₹921.20.
52-week range of traded prices to 23 Oct 2026
₹807.00Low, 30 Mar 2026₹1,729.90High, 29 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,861 Cr807th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 27 Jul 2026
- 14.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 2 May 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.56%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 27 Jul 2026
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- 14.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 2 May 2026
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 42,72442.2% delivered
Epigral share news and announcements
423 announcements, routine notices left out, newest first. Page 4 of 9.
Aug 2024
24 Aug · Analysts
20 Aug · Analysts
20 Aug · Analysts
17 Aug · Meeting
14 Aug · Board meeting
9 Aug · Board meeting
Jul 2024
26 Jul · Analysts
24 Jul · Analysts
24 Jul · Board meeting
19 Jul · Analysts
Jun 2024
25 Jun · Analysts
21 Jun · Analysts
12 Jun · Analysts
11 Jun · Corporate action
May 2024
27 May · Analysts
3 May · Analysts
Apr 2024
24 Apr · Analysts
23 Apr · Analysts
23 Apr · Analysts
17 Apr · Analysts
Mar 2024
8 Mar · Analysts
Feb 2024
26 Feb · Analysts
23 Feb · Analysts
21 Feb · Legal
Significant increase in volume has been observed in Epigral Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.